Patents by Inventor Michael V. Nebozhyn

Michael V. Nebozhyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune Gene Signatures in Cancer
    Publication number: 20210381061
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: May 25, 2021
    Publication date: December 9, 2021
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Audrey Loboda, Michael V. Nebozhyn
  • Immune Gene Signatures in Cancer
    Publication number: 20200399706
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: May 6, 2020
    Publication date: December 24, 2020
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Audrey Loboda, Michael V. Nebozhyn
  • Immune gene signatures in treating breast cancer
    Patent number: 10648040
    Abstract: This invention relates to methods for treating subjects with breast cancer, based on tumor expression levels of chemokines.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: May 12, 2020
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Audrey Loboda, Michael V. Nebozhyn
  • Immune Gene Signatures in Cancer
    Publication number: 20190010556
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: July 6, 2018
    Publication date: January 10, 2019
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Audrey Loboda, Michael V. Nebozhyn
  • Immune gene signatures in cancer
    Patent number: 10041129
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: August 7, 2018
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Andrey Loboda, Michael V. Nebozhyn
  • Immune Gene Signatures in Cancer
    Publication number: 20160326599
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: June 2, 2016
    Publication date: November 10, 2016
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Andrey Loboda, Michael V. Nebozhyn
  • Immune gene signatures in cancer
    Patent number: 9404926
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: August 2, 2016
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Andrey Loboda, Michael V. Nebozhyn
  • Immune Gene Signatures in Cancer
    Publication number: 20130034540
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: January 28, 2011
    Publication date: February 7, 2013
    Applicant: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
    Inventors: James J. Mulé, Domenico Coppola, Timothy J. Yeatman, Andrey Loboda, Michael V. Nebozhyn